Literature DB >> 1708841

Carcinoid tumour of the gastrointestinal tract: prognostic factors and disease outcome.

A L Agranovich1, G H Anderson, M Manji, B D Acker, W C Macdonald, W J Threlfall.   

Abstract

This study represents retrospective analysis of 87 patients with a carcinoid tumour of the gastrointestinal tract seen and followed in the British Columbia Cancer Agency (BCCA) from 1960 to 1986. In 49 cases, the primary site was the small bowel. The rest of the cases were distributed as follows: 11 appendix, 10 rectum, 5 stomach, and 7 undetermined. We extrapolated the Dukes' and modified Astler-Coller surgicopathological classifications used for colorectal cancer for use in our cases of carcinoid tumour of the gastrointestinal tract. A strong correlation was found, using this staging, with disease-specific survival. Other prognostic factors included histologic differentiation, the presence of macroscopic residual disease after initial surgery, and level of 5-hydroxyindoleacetic acid (5-HIAA) in urine. Among 51 patients with surgically grossly removed disease, there was a tendency for the development of distant and distant/locoregional recurrence more often than locoregional recurrence alone. The liver was the commonest site of distant recurrence. Analysis of the effect of radiotherapy or chemotherapy on carcinoid tumour of the gastrointestinal tract proved unsuccessful because only a small portion of the patients had this treatment, and it was used mainly for palliation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708841     DOI: 10.1002/jso.2930470111

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

Authors:  W Kocha; J Maroun; H Kennecke; C Law; P Metrakos; J F Ouellet; R Reid; C Rowsell; A Shah; S Singh; S Van Uum; R Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

2.  Usefulness of transanal endoscopic surgery for carcinoid tumor in the upper and middle rectum.

Authors:  K Ishikawa; T Arita; K Shimoda; Y Hagino; N Shiraishi; S Kitano
Journal:  Surg Endosc       Date:  2005-05-26       Impact factor: 4.584

3.  Transanal endoscopic microsurgery in the treatment of rectal carcinoid tumor.

Authors:  T Kinoshita; E Kanehira; K Omura; T Tomori; H Yamada
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

4.  Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.

Authors:  G B Turner; B T Johnston; D R McCance; A McGinty; R G P Watson; C C Patterson; J E S Ardill
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

5.  Rectal NETs and rectosigmoid junction NETs may need to be treated differently.

Authors:  Wen Cai; Weiting Ge; Hanguang Hu; Jianshan Mao
Journal:  Cancer Med       Date:  2019-12-16       Impact factor: 4.452

6.  Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.

Authors:  Jihye Kim; Jee Hyun Kim; Joo Young Lee; Jaeyoung Chun; Jong Pil Im; Joo Sung Kim
Journal:  BMC Gastroenterol       Date:  2018-06-05       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.